By Dr Farhad Faridhosseini Psychiatrist Mashhad Medical University HTLV1 Topics Prevalence of HTLV1 seropositivity in psychiatric patients Psychiatric complications in HTLV1 carriers or patients ID: 927872
Download Presentation The PPT/PDF document "Psych iatric Aspects of HTLV-1 infection" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Psychiatric Aspects of HTLV-1 infection
By: Dr Farhad Faridhosseini
Psychiatrist
Mashhad Medical University
Slide2HTLV-1
Slide3Topics
Prevalence of HTLV-1
seropositivity
in psychiatric patients.
Psychiatric complications in HTLV-1 carriers or patients.
Psychiatric assessment of these patients.
Pharmacologic & Psychotherapeutic interventions
Slide4Viral Hypothesis for Schizophrenia
Indirect evidence suggest that viral infection during CNS development may be involved in the pathogenesis of schizophrenia:
an excess number of patient births in the late winter and early spring
an association between exposure to viral epidemics in
utero
and the later development of schizophrenia.
a higher prevalence of schizophrenia in crowded urban areas
seroepidemiological
studies indicting a higher infection rate for certain viruses in schizophrenia patients or their
mothers:
Borna
virus, Influenza, Rubella
Slide5Is HTLV-1 infection could be etiology for psychiatric disorders?
Psychiatric patients showed
a
seroprevalence
rate similar to that for the
controls
(
Cubo
et al, 1997, Kagoshima, Japan).
Lack of evidence for retrovirus
infection in
schizophrenic
patients
(
Delisi
et al, 1985)
.
HTLV-1 infection appeared to have no correlation
with psychiatric disorders.
Slide6HTLV-1 & dementia
frequency
of anti-HTLV-I antibody was found to be significantly higher in the patients with dementia
than
in those without
dementia.
Among
the various types of dementia, HTLV-I
seropositivity
was found to be significantly associated with vascular
dementia.
The presence of HTLV-I
appears
to be one of the risk factors for vascular dementia in HTLV-I endemic
areas (
Kira
et al, 1997, Japan)
Slide7IV drug abusers
HTLV-1
infections appear to be widely distributed among high-risk groups in a
nonendemic
area of
Argentina.
co-infection
with HBV and HCV more frequent among
IV Drug Users.
(
Berini
et al. 2007)
HTLV-I is present in Greece among populations at high-risk
.
(
Tseliou
et al. 2006)
Slide8Frequency of psychiatric symptoms in HTLV-1 patients
42%
HTLV-1
patients had
a psychiatric co-morbidity;
34% had
mood disorders,
22% were anxious.
a
higher frequency
of mental disorder in the symptomatic
subgroup, patients on medication & female.
The rate is similar
to those observed in studies carried out
into patients
with chronic diseases (31% to 66%)
and
to
those reported
for HIV patients (45
%).
(
Carvalho
et al, 2009, Brazil)
Slide9Depression in HTLV-1 carriers
The rate of depression was
significantly higher
in HTLV-l carriers when compared with controls (39% vs. 8
%).
It was
not possible
to determine whether depression was related to knowledge of
chronic retroviral
infection or related to a biological effect
of the
retroviral infection
.
(
Stumpf
et al., 2009, Brazil)
donors
seropositive
for HTL V-1/2 had worse scores on a depression
subscale of General Well-Being Scale.
(
Guiltinan
et
al, 1998)
Slide10Relationship between Depression and HTLV-1 infection
chronic viral infection
may
produce a widespread
dysregulation
of the immune system that may lead
to depressive symptoms.
IL-1 & IL-6 have
been associated with depressive symptoms through direct
brain activity.
decreased immune
function associated
with depression could be related to increased susceptibility
to immune-mediated diseases.
stigma and the stress of
having serious
complications like HAM-TSP or ATL may turn patients with
HTLV-I infection
vulnerable to develop
depression.
depressed patients
may be
more likely to engage in behaviors that put them at risk for contracting HTL
V and
other viruses
Slide11Sexual dysfunction
high frequency of urinary and sexual complaints not only in patients with
myelopathy
but also in individuals considered to be HTLV-I
carriers.
(
Oliviera
et al, 2007, Brazil)
The percentage of
Erectile Dysfunction
in the
carriers was
40.5
%
a
nd in HAM/TSP
group, ED frequency was 88.2
%.
(Castro et al, 2005, Brazil)
It may be the first symptom of HAM/TSP.
Slide12Cognitive deficits
Both the HTLV-1 carrier group and the group of patients with TSP/HAM exhibited a lower performance in neuropsychological
tests
(Silva et al, 2003):
Psychomotor slowing, verbal
and visual memory, attention and
visuomotor
abilities.
Progressive Cognitive decline in childhood HAM/TSP
(case report by
Zorzi
et al, 2010).
Subcortical
dementia could be seen
(Cartier et al., 1999)
Slide13Chronic pain
Chronic pain was highly
prevalent.
(
Netto
&
Brites
, 2011)
It
was significantly associated with a
higher likelihood
of signs/symptoms of anxiety and depression,
reflecting a
negative impact of pain on patients´ quality of life.
Slide14Psychiatric assessment
History taking
R/O Depression
Anxiety
Cognitive impairment
Erectile dysfunction
Level of functional impairment
Stigma and patient’s perspective
Health behavior & high risk groups
Drug interaction
Effects of Drugs on psychiatric symptoms.
Slide15Treatment of psychiatric complications
SSRIs are safer except
Fluvoxamine
Buspirone
could be effective
Benzodiazepines could be used but with precaution
Clozapine
is contraindicated because of its
drug interactions
stimulants for cognitive impairment & depression
Treatment of substance dependency
Psychotherapy:
Stigma: education & give information
Uncertainty and anxiety: relaxation, cognitive appraisal
Pain:
mindfullness
deal with many losses
Slide16Thank You